ArticleThe American journal of case reports2025
Sacral Neuromodulation for Post-Hysterectomy Hydroureteronephrosis in a Patient with Cervical Cancer: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Uterine cervical cancer in its early stage is managed with a standard treatment protocol of radical hysterectomy with bilateral pelvic lymphadenectomy. Common complications after the surgery include hydronephrosis, partially leading to renal failure. Currently, there are few reports on upper urinary tract function impairment caused by delayed lower urinary tract dysfunction after radical hysterectomy. Here, we present a case in which sacral neuromodulation (SNM) was successfully used to treat severe hydroureteronephrosis after radical hysterectomy for uterine cervical cancer. CASE REPORT A 44-year-old woman was diagnosed with bilateral hydroureteronephrosis and renal insufficiency (serum creatinine at 287 µmol/L) more than 1 year after undergoing radical hysterectomy for uterine cervical cancer. After utilizing an indwelling catheter for 3 months, her renal function showed a progressive improvement and stabilized at around 126 µmol/L. Videourodynamic study (VUDS) indicated decreased bladder compliance, bilateral ureteral reflux, with the reflux graded as IV-V. After confirmation that the upper urinary tract damage was caused by the elevated bladder pressure and not by invasion of the bladder by the primary tumor, SNM was performed to restore lower urinary tract function and to maintain low-pressure urine storage and micturition. Currently, 4 years after the surgery, the creatinine level has progressively declined to 75 µmol/L. Ultrasonography revealed no signs of hydronephrosis. Routine urine tests and post-void residual urine volumes are normal. CONCLUSIONS In select patients, sacral neuromodulation can protect the upper urinary tract, probably by improving lower urinary tract function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.